Hypoxia Enhances the Proliferative Response of Macrophages to CSF-1 and Their Pro-Survival Response to TNF

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Hamilton, John A ^a   Lacey, Derek C ^a   Turner, Amanda ^a   de Kok, Bernard ^a   Huynh, Jennifer ^a   Scholz, Glen M ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE B; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; ENZYME KINETICS; HYPOXIA; MACROPHAGE; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CELL HYPOXIA; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; ENZYME INHIBITORS; HUMANS; MACROPHAGE COLONY-STIMULATING FACTOR; MACROPHAGES; MICE; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84866542725     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045853     Document Type: Article

References (59)

1. Haslett C, Savill JS, Whyte MK, Stern M, Dransfield I, et al. (1994) Granulocyte apoptosis and the control of inflammation. Philos Trans R Soc Lond B Biol Sci 345: 327-333.
2. Pope RM, (2002) Apoptosis as a therapeutic tool in rheumatoid arthritis. Nat Rev Immunol 2: 527-535.
3. Tak PP, Bresnihan B, (2000) The pathogenesis and prevention of joint damage in rheumatoid arthritis: advances from synovial biopsy and tissue analysis. Arthritis Rheum 43: 2619-2633.
4. Pollard JW, (2004) Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 4: 71-78.
5. Hamilton JA, Tak PP, (2009) The dynamics of macrophage lineage populations in inflammatory and autoimmune diseases. Arthritis Rheum 60: 1210-1221.
6. Tushinski RJ, Oliver IT, Guilbert LJ, Tynan PW, Warner JR, et al. (1982) Survival of mononuclear phagocytes depends on a lineage-specific growth factor that the differentiated cells selectively destroy. Cell 28: 71-81.
7. Kelley TW, Graham MM, Doseff AI, Pomerantz RW, Lau SM, et al. (1999) Macrophage colony-stimulating factor promotes cell survival through Akt/protein kinase B. J Biol Chem. 274: 26393-26398.
8. Murray JT, Craggs G, Wilson L, Kellie S, (2000) Mechanism of phosphatidylinositol 3-kinase-dependent increases in BAC1.2F5 macrophage-like cell density in response to M-CSF: phosphatidylinositol 3-kinase inhibitors increase the rate of apoptosis rather than inhibit DNA synthesis. Inflamm Res 49: 610-618.
9. Comalada M, Xaus J, Sanchez E, Valledor AF, Celada A, (2004) Macrophage colony-stimulating factor-, granulocyte-macrophage colony-stimulating factor-, or IL-3-dependent survival of macrophages, but not proliferation, requires the expression of p21(Waf1) through the phosphatidylinositol 3-kinase/Akt pathway. Eur J Immunol 34: 2257-2267.
10. Wang Y, Zeigler MM, Lam GK, Hunter MG, Eubank TD, et al. (2007) The role of the NADPH oxidase complex, p38 MAPK, and Akt in regulating human monocyte/macrophage survival. Am J Respir Cell Mol Biol 36: 68-77.
11. Muz B, Khan MN, Kiriakidis S, Paleolog EM, (2009) Hypoxia. The role of hypoxia and HIF-dependent signalling events in rheumatoid arthritis. Arthritis Res Ther 11: 201.
12. Mazumder B, Li X, Barik S, (2010) Translation control: a multifaceted regulator of inflammatory response. J Immunol 184: 3311-3319.
13. Cramer T, Yamanishi Y, Clausen BE, Forster I, Pawlinski R, et al. (2003) HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell 112: 645-657.
14. Walmsley SR, Chilvers ER, Whyte MK, (2009) Hypoxia. Hypoxia, hypoxia inducible factor and myeloid cell function. Arthritis Res Ther 11: 219.
15. Negus RP, Turner L, Burke F, Balkwill FR, (1998) Hypoxia down-regulates MCP-1 expression: implications for macrophage distribution in tumors. J Leukoc Biol 63: 758-765.
16. Lewis JS, Lee JA, Underwood JC, Harris AL, Lewis CE, (1999) Macrophage responses to hypoxia: relevance to disease mechanisms. J Leukoc Biol 66: 889-900.
17. Murdoch C, Muthana M, Lewis CE, (2005) Hypoxia regulates macrophage functions in inflammation. J Immunol 175: 6257-6263.
18. Elbarghati L, Murdoch C, Lewis CE, (2008) Effects of hypoxia on transcription factor expression in human monocytes and macrophages. Immunobiology 213: 899-908.
19. Hannah S, Mecklenburgh K, Rahman I, Bellingan GJ, Greening A, et al. (1995) Hypoxia prolongs neutrophil survival in vitro. FEBS Lett 372: 233-237.
20. Walmsley SR, Print C, Farahi N, Peyssonnaux C, Johnson RS, et al. (2005) Hypoxia-induced neutrophil survival is mediated by HIF-1alpha-dependent NF-kappaB activity. J Exp Med 201: 105-115.
21. Rymsa B, Becker HD, Lauchart W, de Groot H, (1990) Hypoxia/reoxygenation injury in liver: Kupffer cells are much more vulnerable to reoxygenation than to hypoxia. Res Commun Chem Pathol Pharmacol 68: 263-266.
22. Yun JK, McCormick TS, Villabona C, Judware RR, Espinosa MB, et al. (1997) Inflammatory mediators are perpetuated in macrophages resistant to apoptosis induced by hypoxia. Proc Natl Acad Sci U S A 94: 13903-13908.
23. Fong CC, Zhang Q, Shi YF, Wu RS, Fong WF, et al. (2007) Effect of hypoxia on RAW264.7 macrophages apoptosis and signaling. Toxicology 235: 52-61.
24. Degrossoli A, Giorgio S, (2007) Functional alterations in macrophages after hypoxia selection. Exp Biol Med (Maywood) 232: 88-95.
25. Roiniotis J, Dinh H, Masendycz P, Turner A, Elsegood CL, et al. (2009) Hypoxia prolongs monocyte/macrophage survival and enhanced glycolysis is associated with their maturation under aerobic conditions. J Immunol 182: 7974-7981.
26. Smeets TJ, Kraan MC, van Loon ME, Tak PP, (2003) Tumor necrosis factor alpha blockade reduces the synovial cell infiltrate early after initiation of treatment, but apparently not by induction of apoptosis in synovial tissue. Arthritis Rheum 48: 2155-2162.
27. Catrina AI, Trollmo C, af Klint E, Engstrom M, Lampa J, et al. (2005) Evidence that anti-tumor necrosis factor therapy with both etanercept and infliximab induces apoptosis in macrophages, but not lymphocytes, in rheumatoid arthritis joints: extended report. Arthritis Rheum 52: 61-72.
28. Matsui T, Nakata N, Nagai S, Nakatani A, Takahashi M, et al. (2009) Inflammatory cytokines and hypoxia contribute to 18F-FDG uptake by cells involved in pannus formation in rheumatoid arthritis. J Nucl Med 50: 920-926.
29. Meszaros K, Lang CH, Bagby GJ, Spitzer JJ, (1987) Tumor necrosis factor increases in vivo glucose utilization of macrophage-rich tissues. Biochem Biophys Res Commun 149: 1-6.
30. Hamilton JA, Vairo G, Lingelbach SR, (1986) CSF-1 stimulates glucose uptake in murine bone marrow-derived macrophages. Biochem Biophys Res Commun 138: 445-454.
31. Hamilton JA, Vairo G, Lingelbach SR, (1988) Activation and proliferation signals in murine macrophages: stimulation of glucose uptake by hemopoietic growth factors and other agents. J Cell Physiol 134: 405-412.
32. Elsegood CL, Chang M, Jessup W, Scholz GM, Hamilton JA, (2009) Glucose metabolism is required for oxidized LDL-induced macrophage survival: role of PI3K and Bcl-2 family proteins. Arterioscler Thromb Vasc Biol 29: 1283-1289.
33. Chang M, Hamilton JA, Scholz GM, Masendycz P, Macaulay SL, et al. (2009) Phosphatidylinostitol-3 kinase and phospholipase C enhance CSF-1-dependent macrophage survival by controlling glucose uptake. Cell Signal 21: 1361-1369.
34. Chang M, Hamilton JA, Scholz GM, Elsegood CL, (2009) Glycolytic control of adjuvant-induced macrophage survival: role of PI3K, MEK1/2, and Bcl-2. J Leukoc Biol 85: 947-956.
35. Xaus J, Comalada M, Valledor AF, Lloberas J, Lopez-Soriano F, et al. (2000) LPS induces apoptosis in macrophages mostly through the autocrine production of TNF-alpha. Blood 95: 3823-3831.
36. Comalada M, Xaus J, Valledor AF, Lopez-Lopez C, Pennington DJ, et al. (2003) PKC epsilon is involved in JNK activation that mediates LPS-induced TNF-alpha, which induces apoptosis in macrophages. Am J Physiol Cell Physiol 285: C1235-1245.
37. Lombardo E, Alvarez-Barrientos A, Maroto B, Bosca L, Knaus UG, (2007) TLR4-mediated survival of macrophages is MyD88 dependent and requires TNF-alpha autocrine signalling. J Immunol 178: 3731-3739.
38. Lo SZ, Steer JH, Joyce DA, (2011) TNF-alpha renders macrophages resistant to a range of cancer chemotherapeutic agents through NF-kappaB-mediated antagonism of apoptosis signalling. Cancer Lett 307: 80-92.
39. Sester DP, Brion K, Trieu A, Goodridge HS, Roberts TL, et al. (2006) CpG DNA activates survival in murine macrophages through TLR9 and the phosphatidylinositol 3-kinase-Akt pathway. J Immunol 177: 4473-4480.
40. Hamilton JA, Byrne R, Whitty G, Vadiveloo PK, Marmy N, et al. (1998) Effects of wortmannin and rapamycin on CSF-1-mediated responses in macrophages. Int J Biochem Cell Biol 30: 271-283.
41. Hamilton JA, Byrne R, Jessup W, Kanagasundaram V, Whitty G, (2001) Comparison of macrophage responses to oxidized low-density lipoprotein and macrophage colony-stimulating factor (M-CSF or CSF-1). Biochem J 354: 179-187.
42. Vairo G, Hamilton JA, (1985) CSF-1 stimulates Na+K+-ATPase mediated 86Rb+ uptake in mouse bone marrow-derived macrophages. Biochem Biophys Res Commun 132: 430-437.
43. Hamilton JA, Myers D, Jessup W, Cochrane F, Byrne R, et al. (1999) Oxidized LDL can induce macrophage survival, DNA synthesis, and enhanced proliferative response to CSF-1 and GM-CSF. Arterioscler Thromb Vasc Biol 19: 98-105.
44. Cecchini MG, Dominguez MG, Mocci S, Wetterwald A, Felix R, et al. (1994) Role of colony stimulating factor-1 in the establishment and regulation of tissue macrophages during postnatal development of the mouse. Development 120: 1357-1372.
45. Pixley FJ, Stanley ER, (2004) CSF-1 regulation of the wandering macrophage: complexity in action. Trends Cell Biol 14: 628-638.
46. Chandel NS, Trzyna WC, McClintock DS, Schumacker PT, (2000) Role of oxidants in NF-kappa B activation and TNF-alpha gene transcription induced by hypoxia and endotoxin. J Immunol 165: 1013-1021.
47. Choi HK, Kim TH, Jhon GJ, Lee SY, (2011) Reactive oxygen species regulate M-CSF-induced monocyte/macrophage proliferation through SHP1 oxidation. Cell Signal 23: 1633-1639.
48. Morgan MJ, Liu ZG, (2011) Crosstalk of reactive oxygen species and NF-kappaB signaling. Cell Res 21: 103-115.
49. Bubici C, Papa S, Dean K, Franzoso G, (2006) Mutual cross-talk between reactive oxygen species and nuclear factor-kappa B: molecular basis and biological significance. Oncogene 25: 6731-6748.
50. Murray J, Wilson L, Kellie S, (2000) Phosphatidylinositol-3′ kinase-dependent vesicle formation in macrophages in response to macrophage colony stimulating factor. J Cell Sci 113 Pt 2: 337-348.
51. Sugatani T, Hruska KA, (2005) Akt1/Akt2 and mammalian target of rapamycin/Bim play critical roles in osteoclast differentiation and survival, respectively, whereas Akt is dispensable for cell survival in isolated osteoclast precursors. J Biol Chem 280: 3583-3589.
52. Kim HJ, Oh JE, Kim SW, Chun YJ, Kim MY, (2008) Ceramide induces p38 MAPK-dependent apoptosis and Bax translocation via inhibition of Akt in HL-60 cells. Cancer Lett 260: 88-95.
53. Rane MJ, Coxon PY, Powell DW, Webster R, Klein JB, et al. (2001) p38 Kinase-dependent MAPKAPK-2 activation functions as 3-phosphoinositide-dependent kinase-2 for Akt in human neutrophils. J Biol Chem 276: 3517-3523.
54. Hamilton JA, Byrne R, Whitty G, (2000) Particulate adjuvants can induce macrophage survival, DNA synthesis, and a synergistic proliferative response to GM-CSF and CSF-1. J Leukoc Biol 67: 226-232.
55. Hamilton JA, (2003) Nondisposable materials, chronic inflammation, and adjuvant action. J Leukoc Biol 73: 702-712.
56. Hamilton JA, (1993) Rheumatoid arthritis: opposing actions of haemopoietic growth factors and slow-acting anti-rheumatic drugs. Lancet 342: 536-539.
57. Wang Y, Roche O, Yan MS, Finak G, Evans AJ, et al. (2009) Regulation of endocytosis via the oxygen-sensing pathway. Nat Med 15: 319-324.
58. Mangan DF, Welch GR, Wahl SM, (1991) Lipopolysaccharide, tumor necrosis factor-alpha, and IL-1 beta prevent programmed cell death (apoptosis) in human peripheral blood monocytes. J Immunol 146: 1541-1546.
59. Nizet V, Johnson RS, (2009) Interdependence of hypoxic and innate immune responses. Nat Rev Immunol 9: 609-617.